ME Therapeutics Holdings Inc.

CNSX:METX Stock Report

Market Cap: CA$93.6m

ME Therapeutics Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

CNSX:METX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Dec 23SellCA$5,200Kenneth HarderIndividual6,500CA$0.80

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of METX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies73,3330.31%
General Public11,042,17646.7%
Individual Insiders12,518,92953%

Dilution of Shares: METX only recently listed within the past 12 months


Top Shareholders

Top 4 shareholders own 53.28% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.7%
Salim Dhanji
4,175,143CA$16.5m0%no data
17.7%
John Priatel
4,175,143CA$16.5m0%no data
17.6%
Kenneth Harder
4,168,643CA$16.5m0%no data
0.31%
Donaldson Brohman Martin, CPA Inc.
73,333CA$290.4k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.